Skip to main content
Explore URMC

About Wilmot Cancer Institute

WCC atriumUR Medicine's Wilmot Cancer Institute provides world-class cancer treatment and care. With a commitment to conquer cancer, and through its leadership in innovative medicine, research, and education, Wilmot is achieving tremendous progress in cancer prevention, care, and survivorship.

Wilmot maintains a large network of clinical trials offering new therapies, and it offers patients and their families comprehensive services, including one of Upstate New York's largest blood and marrow transplant program and the Rochester area's only ACOS-accredited breast cancer center. It features an 87-bed cancer center with 13 outpatient locations throughout the Rochester and Finger Lakes region. Wilmot is a component of Strong Memorial Hospital and is home to the region’s first survivorship clinic. In addition, Wilmot includes a team of scientists who investigate many aspects of cancer, with an emphasis on how best to provide precision cancer care.

Established in 1974 as the University of Rochester Cancer Center, Wilmot Cancer Institute has its roots in an era that encouraged academic medical centers to bring their expertise in fields such as cancer to regional communities. Wilmot Cancer Institute has stayed true to that vision and, through its network of locations, provides patients and families comprehensive cancer care closer to where they live and work.

The Wilmot Cancer Institute is named for James P. Wilmot, a prominent local businessman, philanthropist and leading member of the Rochester community. Wilmot created the Wilmot Foundation, which is dedicated to attracting, training and supporting doctors who are pursuing a career in cancer research. The Foundation provides fellowships to young medical doctors so they can pursue their research goals.

Our Vision

Patients at Wilmot Cancer Institute will survive and thrive following treatment and care, while dedicated clinicians, scientists, and researchers continue the quest to conquer all cancers. 

Our Mission

Wilmot Cancer Institute is committed to providing the highest-quality treatment and care — through expert and innovative medicine, science, and education — for any patient burdened by any cancer within our region and beyond. 

Our Shared Values

Patient Outcomes • Pursuit of Excellence • Cutting-Edge Discoveries • Diversity, Inclusion, and Equality • Teamwork and Collaboration • Caring and Compassion • Commitment to Our Region

Facts at a Glance

In FY2019, WCI provided care for more than 36,000 patients from across upstate New York.

  • Outpatient clinic visits and procedures: 250,038
  • Inpatient admissions: 2,881

Approximately 120 physicians provide oncology care throughout the Institute.

More than 500 registered nurses and advanced practice providers care for our patients. 

More than 270 aspiring physicians and researchers are training with Wilmot mentors. 

Director: Jonathan W. Friedberg, M.D., M.M.Sc.

Deputy Director: Hartmut “Hucky” Land, Ph.D.

Wilmot had more than 551 patients participate in therapeutic interventional clinical trials in 2019. 

Wilmot has $29.4 million in annual direct funding for cancer research. 

Wilmot Cancer Institute is proud to be part of: 

National Clinical Trials Network

NCI Community Oncology Research Program